José Aguado to Humans
This is a "connection" page, showing publications José Aguado has written about Humans.
Connection Strength
0.157
-
Intravenous immunoglobulins for the treatment of the hyper-inflammatory response in COVID-19. Another failure of immunomodulatory therapy? Clin Microbiol Infect. 2021 10; 27(10):1386-1388.
Score: 0.008
-
SARS-CoV-2-specific Cell-mediated Immunity in Kidney Transplant Recipients Recovered From COVID-19. Transplantation. 2021 06 01; 105(6):1372-1380.
Score: 0.008
-
Inhaled budesonide for early treatment of COVID-19. Lancet Respir Med. 2021 07; 9(7):e58.
Score: 0.008
-
Effectiveness of anakinra for tocilizumab-refractory severe COVID-19: A single-centre retrospective comparative study. Int J Infect Dis. 2021 Apr; 105:319-325.
Score: 0.007
-
Tocilizumab for the treatment of adult patients with severe COVID-19 pneumonia: A single-center cohort study. J Med Virol. 2021 02; 93(2):831-842.
Score: 0.007
-
Low 25-hydroxyvitamin D Levels and the Risk of Late CMV Infection After Kidney Transplantation: Role for CMV-specific Mediated Immunity. Transplantation. 2019 08; 103(8):e216-e217.
Score: 0.007
-
A short course of antibiotic treatment is safe after catheter withdrawal in catheter-related bloodstream infections due to coagulase-negative staphylococci. Eur J Clin Microbiol Infect Dis. 2019 May; 38(5):977-983.
Score: 0.007
-
Multidrug-resistant Gram-negative infection in solid organ transplant recipients: implications for outcome and treatment. Curr Opin Infect Dis. 2018 12; 31(6):499-505.
Score: 0.006
-
[Invasive aspergillosis in solid organ transplantation]. Rev Iberoam Micol. 2018 Oct - Dec; 35(4):206-209.
Score: 0.006
-
Risk of infection associated with anti-TNF-a therapy. Expert Rev Anti Infect Ther. 2018 12; 16(12):939-956.
Score: 0.006
-
Impact on mortality of adherence to evidence-based interventions in patients with catheter-related bloodstream infection due to methicillin-sensitive Staphylococcus aureus. Infect Dis (Lond). 2018 Nov - Dec; 50(11-12):837-846.
Score: 0.006
-
Viral infections in the biologic therapy era. Expert Rev Anti Infect Ther. 2018 10; 16(10):781-791.
Score: 0.006
-
Vitamin D deficiency and infection risk in kidney transplant recipients: A single-center cohort study. Transpl Infect Dis. 2018 Dec; 20(6):e12988.
Score: 0.006
-
Post-transplant hypocomplementemia: A novel marker of cardiovascular risk in kidney transplant recipients? Atherosclerosis. 2018 02; 269:204-210.
Score: 0.006
-
Association between baseline serum hepcidin levels and infection in kidney transplant recipients: Potential role for iron overload. Transpl Infect Dis. 2018 Feb; 20(1).
Score: 0.006
-
Herpes zoster in kidney transplant recipients: protective effect of anti-cytomegalovirus prophylaxis and natural killer cell count. A single-center cohort study. Transpl Int. 2018 02; 31(2):187-197.
Score: 0.006
-
Environmental Factors as Key Determinants for Visceral Leishmaniasis in Solid Organ Transplant Recipients, Madrid, Spain. Emerg Infect Dis. 2017 07; 23(7):1155-1159.
Score: 0.006
-
Serum sCD30: A promising biomarker for predicting the risk of bacterial infection after kidney transplantation. Transpl Infect Dis. 2017 Apr; 19(2).
Score: 0.006
-
Risk factors for unfavorable outcome and impact of early post-transplant infection in solid organ recipients with COVID-19: A prospective multicenter cohort study. PLoS One. 2021; 16(4):e0250796.
Score: 0.002
-
IL-6-based mortality prediction model for COVID-19: Validation and update in multicenter and second wave cohorts. J Allergy Clin Immunol. 2021 05; 147(5):1652-1661.e1.
Score: 0.002
-
Combination therapy with tocilizumab and corticosteroids for aged patients with severe COVID-19 pneumonia: A single-center retrospective study. Int J Infect Dis. 2021 Apr; 105:487-494.
Score: 0.002
-
Impact of viral load at admission on the development of respiratory failure in hospitalized patients with SARS-CoV-2 infection. Eur J Clin Microbiol Infect Dis. 2021 Jun; 40(6):1209-1216.
Score: 0.002
-
Invasive pulmonary aspergillosis associated with COVID-19 in a kidney transplant recipient. Transpl Infect Dis. 2021 Apr; 23(2):e13501.
Score: 0.002
-
Tocilizumab use in Kidney Transplant Patients with COVID-19. Clin Transplant. 2020 11; 34(11):e14072.
Score: 0.002
-
Clinical course and risk factors for mortality from COVID-19 in patients with haematological malignancies. Eur J Haematol. 2020 Nov; 105(5):597-607.
Score: 0.002
-
IL-6-based mortality risk model for hospitalized patients with COVID-19. J Allergy Clin Immunol. 2020 10; 146(4):799-807.e9.
Score: 0.002
-
Varied clinical presentation and outcome of SARS-CoV-2 infection in liver transplant recipients: Initial experience at a single center in Madrid, Spain. Transpl Infect Dis. 2020 Oct; 22(5):e13372.
Score: 0.002
-
Extended-pulsed fidaxomicin versus vancomycin in patients 60 years and older with Clostridium difficile infection: cost-effectiveness analysis in Spain. Eur J Clin Microbiol Infect Dis. 2019 Jun; 38(6):1105-1111.
Score: 0.002
-
Going beyond serology for stratifying the risk of CMV infection in transplant recipients. Rev Med Virol. 2019 01; 29(1):e2017.
Score: 0.002
-
Diagnosis and management of asymptomatic bacteriuria in kidney transplant recipients: a survey of current practice in Europe. Nephrol Dial Transplant. 2018 09 01; 33(9):1661-1668.
Score: 0.002
-
T2Candida MR as a predictor of outcome in patients with suspected invasive candidiasis starting empirical antifungal treatment: a prospective pilot study. J Antimicrob Chemother. 2018 03 01; 73(suppl_4):iv6-iv12.
Score: 0.002
-
T2MR contributes to the very early diagnosis of complicated candidaemia. A prospective study. J Antimicrob Chemother. 2018 03 01; 73(suppl_4):iv13-iv19.
Score: 0.002
-
Impact of anti-HCV direct antiviral agents on graft function and immunosuppressive drug levels in kidney transplant recipients: a call to attention in the mid-term follow-up in a single-center cohort study. Transpl Int. 2018 08; 31(8):887-899.
Score: 0.002
-
Tuberculosis Recommendations for Solid Organ Transplant Recipients and Donors. Transplantation. 2018 02; 102(2S Suppl 2):S60-S65.
Score: 0.002
-
Recommendations for Management of Endemic Diseases and Travel Medicine in Solid-Organ Transplant Recipients and Donors: Latin America. Transplantation. 2018 02; 102(2):193-208.
Score: 0.002
-
Experience with leflunomide as treatment and as secondary prophylaxis for cytomegalovirus infection in lung transplant recipients: A case series and review of the literature. Clin Transplant. 2018 02; 32(2).
Score: 0.001
-
Extended-pulsed fidaxomicin versus vancomycin for Clostridium difficile infection in patients 60 years and older (EXTEND): a randomised, controlled, open-label, phase 3b/4 trial. Lancet Infect Dis. 2018 03; 18(3):296-307.
Score: 0.001
-
Cytomegalovirus infection management in solid organ transplant recipients across European centers in the time of molecular diagnostics: An ESGICH survey. Transpl Infect Dis. 2017 Dec; 19(6).
Score: 0.001
-
High vancomycin MICs predict the development of infective endocarditis in patients with catheter-related bacteraemia due to methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother. 2017 07 01; 72(7):2102-2109.
Score: 0.001
-
Detection of cytomegalovirus drug resistance mutations in solid organ transplant recipients with suspected resistance. J Clin Virol. 2017 05; 90:57-63.
Score: 0.001
-
EPICO 3.0. Antifungal prophylaxis in solid organ transplant recipients. Rev Iberoam Micol. 2016 Oct - Dec; 33(4):187-195.
Score: 0.001
-
Initial use of echinocandins does not negatively influence outcome in Candida parapsilosis bloodstream infection: a propensity score analysis. Clin Infect Dis. 2014 May; 58(10):1413-21.
Score: 0.001
-
[Consensus document for the treatment of bacteremia and endocarditis caused by methicillin-resistent Staphylococcus aureus. Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica]. Enferm Infecc Microbiol Clin. 2009 Feb; 27(2):105-15.
Score: 0.001